
Cancel anytime
- Chart
- Upturn Summary
- Highlights
Upturn AI SWOT
- About
iShares U.S. Medical Devices ETF (IHI)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/15/2025: IHI (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Analysis of Past Performance
Type ETF | Historic Profit -8.74% | Avg. Invested days 35 | Today’s Advisory WEAK BUY |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | ETF Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Volume (30-day avg) - | Beta 1.01 | 52 Weeks Range 52.86 - 65.09 | Updated Date 06/29/2025 |
52 Weeks Range 52.86 - 65.09 | Updated Date 06/29/2025 |
Upturn AI SWOT
iShares U.S. Medical Devices ETF
ETF Overview
Overview
The iShares U.S. Medical Devices ETF (IHI) seeks to track the investment results of an index composed of U.S. equities in the medical devices sector. It offers exposure to manufacturers, distributors, and suppliers of medical devices.
Reputation and Reliability
iShares is a reputable and reliable issuer with a long track record in the ETF market.
Management Expertise
iShares benefits from BlackRock's extensive experience in investment management and ETF product development.
Investment Objective
Goal
To track the investment results of an index composed of U.S. equities in the medical devices sector.
Investment Approach and Strategy
Strategy: Tracks a market-cap-weighted index of U.S. medical device companies.
Composition Primarily holds stocks of companies involved in the medical devices industry.
Market Position
Market Share: IHI holds a significant market share in the medical devices ETF sector, being one of the oldest and most established funds.
Total Net Assets (AUM): 6660000000
Competitors
Key Competitors
- SPDR S&P Health Care Equipment ETF (XHE)
- Invesco Dynamic Medical Devices ETF (PZD)
- First Trust Nasdaq Lux Biomedical & Devices ETF (FBT)
Competitive Landscape
IHI dominates the market share due to its large AUM and long-standing presence. XHE provides broader healthcare exposure, while PZD and FBT offer different weighting methodologies. IHI is advantageous due to its narrow focus, potentially leading to higher growth, while its competitors provide more diversification.
Financial Performance
Historical Performance: Past performance is not indicative of future results.
Benchmark Comparison: The ETF aims to closely track its underlying index's performance.
Expense Ratio: 0.42
Liquidity
Average Trading Volume
IHI demonstrates high liquidity with a substantial average daily trading volume.
Bid-Ask Spread
The bid-ask spread for IHI is generally tight, reflecting its liquidity.
Market Dynamics
Market Environment Factors
Factors influencing IHI include healthcare spending trends, technological advancements in medical devices, regulatory changes, and demographic shifts.
Growth Trajectory
IHI's growth is tied to the overall growth of the medical devices industry and its ability to maintain its market share and track its benchmark.
Moat and Competitive Advantages
Competitive Edge
IHI's competitive edge stems from its established brand recognition, large AUM, and focused exposure to the U.S. medical devices sector. It benefits from the strength of the iShares brand and the backing of BlackRock's resources. The ETFu2019s focused strategy allows it to concentrate on high-growth potential areas within the medical device industry. Its large AUM also allows for tighter bid-ask spreads, further attracting investors. This combination makes it a preferred choice for investors seeking targeted exposure to this sector.
Risk Analysis
Volatility
IHI's volatility can be influenced by market fluctuations and sector-specific news.
Market Risk
Market risk is the biggest risk, as the fund is sensitive to changes in economic conditions, and healthcare regulations.
Investor Profile
Ideal Investor Profile
IHI is suitable for investors seeking targeted exposure to the U.S. medical devices sector.
Market Risk
IHI is best suited for long-term investors who believe in the growth potential of the medical devices industry.
Summary
The iShares U.S. Medical Devices ETF (IHI) provides targeted exposure to U.S. companies in the medical devices sector. It is a well-established ETF with high liquidity and a significant market share. IHI's performance is closely tied to the medical devices industry, making it suitable for long-term investors bullish on this sector. Its relatively low expense ratio and backing by BlackRock add to its appeal. However, investors should be aware of sector-specific risks and market volatility.
Peer Comparison
Sources and Disclaimers
Data Sources:
- iShares Official Website
- ETF.com
- Yahoo Finance
- SEC Filings
Disclaimers:
This analysis is for informational purposes only and does not constitute financial advice. Past performance is not indicative of future results. Investors should consult with a qualified financial advisor before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About iShares U.S. Medical Devices ETF
Exchange NYSE ARCA | Headquaters - | ||
IPO Launch date - | CEO - | ||
Sector - | Industry - | Full time employees - | Website |
Full time employees - | Website |
The fund seeks to track the investment results of the Dow Jones U.S. Select Medical Equipment Index, which measures the performance of the medical equipment sector of the U.S. equity market, as defined by S&P Dow Jones Indices LLC. The index includes medical equipment companies, including manufacturers and distributors of medical devices such as magnetic resonance imaging scanners, prosthetics, pacemakers, X-ray machines, and other non-disposable medical devices. The fund is non-diversified.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.